Alexander Mark Phillips

Dr. Alexander Mark Phillips

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2019 in Communications Biology
Verified
Journal Article
Open access
PDF file
JXJingshu Xu
Jingshu Xu
SPStefano Patassini
Stefano Patassini
NRNitin Rustogi
Nitin Rustogi
IRIsabel Riba-Garcia
Isabel Riba-Garcia
BHBenjamin D. Hale
Benjamin D. Hale
RURichard Unwin
Richard Unwin
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that currently affects 36 million people worldwide with no effective treatment available. Development of AD follows a distinctive pattern in the brain and is poorly modelled in animals. Therefore, it is vital to widen the spatial scope of the study of AD and prioritise the study of human brains. Here we show that functionally distinct human brain regions display varying and region-specific changes in protein expression. These changes provide insights into the progression of disease, novel AD-related pathways, the presence of a gradient of protein expression change from less to more affected regions and a possibly protective protein expression profile in the cerebellum. This spatial proteomics analysis provides a framework which can underpin current research and open new avenues to enhance molecular understanding of AD pathophysiology, provide new targets for intervention and broaden the conceptual frameworks for future AD research.

13 May 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
SMSelina Mcharg
Selina Mcharg
LBLaura Booth
Laura Booth
RPRahat Perveen
Rahat Perveen
IGIsabel Riba Garcia
Isabel Riba Garcia
NBNicole Brace
Nicole Brace
PBPaul Bishop
Paul Bishop
Significance: Genome-wide association studies have identified two major risk loci for age-related macular degeneration (AMD) on chromosome (Chr) 1 and Chr10. Here, we use proteomics to analyze submacular stromal tissue punches from older eye donors without AMD, comparing tissue from donors who were homozygous for high-risk alleles at Chr1 or Chr10 with tissue from donors with low risk at these two loci. A common change found in Chr1/Chr10–risk eyes was increased mast cell proteases, and immunohistochemistry confirmed the presence of increased mast cell numbers. This study, therefore, provides a unifying mechanistic link between Chr1 and Chr10 risk and suggests that mast cell infiltration of the choroid and degranulation are early events in AMD pathogenesis.

1 October 2019 in Molecular Metabolism
Verified
Journal Article
Open access
SKSarah Kassab
Sarah Kassab
PBPaul Begley
Paul Begley
SCStephanie J. Church
Stephanie J. Church
SRSanziana M. Rotariu
Sanziana M. Rotariu
CCCleo Chevalier-Riffard
Cleo Chevalier-Riffard
NGNatalie J. Gardiner
Natalie J. Gardiner
The impact of diabetes mellitus on the central nervous system is less widely studied than in the peripheral nervous system, but there is increasing evidence that it elevates the risk of developing cognitive deficits. The aim of this study was to characterize the impact of experimental diabetes on the proteome and metabolome of the hippocampus. We tested the hypothesis that the vitamin B6 isoform pyridoxamine is protective against functional and molecular changes in diabetes. We tested recognition memory using the novel object recognition (NOR) test in streptozotocin (STZ)-induced diabetic, age-matched control, and pyridoxamine- or insulin-treated diabetic male Wistar rats. Comprehensive untargeted metabolomic and proteomic analyses, using gas chromatography-mass spectrometry and iTRAQ-enabled protein quantitation respectively, were utilized to characterize the molecular changes in the hippocampus in diabetes. We demonstrated diabetes-specific, long-term (but not short-term) recognition memory impairment and that this deficit was prevented by insulin or pyridoxamine treatment. Metabolomic analysis showed diabetes-associated changes in 13/82 identified metabolites including polyol pathway intermediates glucose (9.2-fold), fructose (4.9-fold) and sorbitol (5.2-fold). We identified and quantified 4807 hippocampal proteins; 806 were significantly altered in diabetes. Pathway analysis revealed significant alterations in cytoskeletal components associated with synaptic plasticity, glutamatergic signaling, oxidative stress, DNA damage and FXR/RXR activation pathways in the diabetic rat hippocampus. Our data indicate a protective effect of pyridoxamine against diabetes-induced cognitive deficits, and our comprehensive 'omics datasets provide insight into the pathogenesis of cognitive dysfunction enabling development of further mechanistic and therapeutic studies.

1 June 2022 in AVS Quantum Science
Verified
Journal Article
Open access
PDF file
APAlexander Mark Phillips
Alexander Mark Phillips
MWMichael J. Wright
Michael J. Wright
IRIsabelle Riou
Isabelle Riou
SMStephen Maddox
Stephen Maddox
SMSimon Maskell
Simon Maskell
JRJason F. F Ralph
Jason F. F Ralph
This paper proposes a position fixing method for autonomous navigation using partial gravity gradient solutions from cold atom interferometers. Cold atom quantum sensors can provide ultra-precise measurements of inertial quantities, such as acceleration and rotation rates. However, we investigate the use of pairs of cold atom interferometers to measure the local gravity gradient and to provide position information by referencing these measurements against a suitable database. Simulating the motion of a vehicle, we use partial gravity gradient measurements to reduce the positional drift associated with inertial navigation systems. Using standard open source global gravity databases, we show stable navigation solutions for trajectories of over 1000 km.

16 November 2024 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
JMJonathon Mellor
Jonathon Mellor
MFMartyn Fyles
Martyn Fyles
RPRobert S. Paton
Robert S. Paton
APAlexander Mark Phillips
Alexander Mark Phillips
COChristopher E. Overton
Christopher E. Overton
TWThomas Ward
Thomas Ward
Influenza-like-illness (ILI) is a commonly used symptom categorization in seasonal disease surveillance focusing on influenza in community and clinical settings. However, SARS-CoV-2 often causes presentation with a similar symptom profile. We explore how SARS-CoV-2-positive individuals can influence surveillance trends for the World Health Organization, the United States Centre for Disease Control, and the European Centre for Disease Control (ECDC) ILI criteria. Harnessing the Winter COVID-19 Infection Study in England, a cohort study, the prevalence of different ILI definitions is modeled using multilevel regression and poststratification using age and spatial stratifications with temporal smoothing. Trends over time across stratifications were compared for SARS-CoV-2 positive and negative individuals to understand differences in ILI trends. Symptom presentation across positive and negative SARS-CoV-2 cases were compared. SARS-CoV-2 symptom profiles are shown to overlap with the ILI case definitions, particularly for "cough" and "fever", causing SARS-CoV-2 positive individuals to be frequently detected as ILI cases. The trend of SARS-CoV-2 positives is a substantial component of the ILI-modeled trend, driving an earlier perceived peak in prevalence. The ECDC symptom definition was most influenced by SARS-CoV-2 positive individuals. Using a large community cohort we show how SARS-CoV-2 can impact ILI surveillance trends. SARS-CoV-2 makes up a substantial part of the community ILI burden and public health messaging should reflect this when discussing ILI. We show ILI is no longer a strong proxy for influenza activity alone.

21 September 2022 in Matrix Biology
Verified
Journal Article
Closed access
FJFiona K. Jones
Fiona K. Jones
APAlexander Mark Phillips
Alexander Mark Phillips
AJAndrew R. Jones
Andrew R. Jones
APAddolorata Pisconti
Addolorata Pisconti